Correction: A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro
Henry Querfurth, John Marshall, Keykavous Parang, Mengia S. Rioult-Pedotti, Rakesh Tiwari, Bumsup Kwon, Steve Reisinger, Han-Kyu Lee
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdipose Tissue and Metabolism · Tryptophan and brain disorders · Calcium signaling and nucleotide metabolism
There is an error in affiliation 3 for authors Keykavous Parang and Rakesh Tiwari. The correct affiliation 3 is: Center for Targeted Drug Delivery, Chapman University, School of Pharmacy, Irvine, CA, United States of America.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Querfurth H, Marshall J, Parang K, Rioult-Pedotti MS, Tiwari R, Kwon B, et al. (2022) A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro. P Lo S ONE 17(1): e 0261696. doi: 10.1371/journal.pone.0261696 35061720 PMC 8782417 · doi ↗ · pubmed ↗